Download PDF
Drug Res (Stuttg) 2015; 65(06): 306-311
DOI: 10.1055/s-0034-1382010
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Evaluation of Antidepressant-like Effect of Olax Subscorpioidea Oliv. (Olacaceae) Extract in Mice

O. A. Adeoluwa
1   Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria
,
A. O. Aderibigbe
1   Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria
,
A. G. Bakre
1   Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria
› Author Affiliations
Further Information

Publication History

received 06 March 2014

accepted 16 May 2014

Publication Date:
03 July 2014 (online)

Also available at
   Permissions and Reprints

Abstract

Olax subscorpioidea is a shrub or tree found in Nigeria, and other parts of Africa. It is indicated in the management of inflammatory disorder, mental illness, convulsion, pain, and cancer.

Based on the folkloric use in the management of mental illness, antidepressant activity of Olax subscorpioidea (6.25–50 mg/kg, i. p.) was investigated using forced swimming, tail suspension, yohimbine induced lethality and reserpine induced depression tests.

The results showed that, Olax subscorpioidea produced significant dose dependent reduction in immobility time in forced swimming [F (5, 24)=17.22, p<0.0001] and tail suspension [F (5, 24)=14.94, p<0.0001] tests without causing changes in locomotor activity in open field test. It was also found that Olax subscorpioidea significantly reduced diarrhea in reserpine model of depression [F (5, 24)=10, p<0.0001]. None of the doses potentiated yohimbine induced lethality in mice. In conclusion Olax subscorpioidea possessed antidepressant action, thus justifying its use in the management of mental illness.

Key words

antidepressant - mental illness - immobility - Olax subscorpioidea - yohimbine
 

  • References

  • 1 Lépine JP, Briley M. The increasing burden of depression Neuropsychiatric Disease and Treatment 2011; 3-1
    PubMed
  • 2 WHO . Mental and Neurological Disorders. Fact sheet No. 25. World Health Organization; 1998
    Google Scholar
  • 3 Richelson E. Mayo Clin Proc 2001; 76: 516-527
    PubMed
  • 4 Ebmeier KP, Donaghey C, Steele JC. Recent developments and current controversies in depression. Lancet 2006; 367: 153-167
    CrossrefPubMedGoogle Scholar
  • 5 Nestler EJ, Barrot M, DiLeone RJ et al. Neurobiology of depression. Neuron 2002; 34: 13-25
    CrossrefPubMedGoogle Scholar
  • 6 Dhingra S, Parle M. Herbal remedies and nutritional supplements in the treatment of depression: a review. Bulletin of Clinical Psychopharmacology 2012; 22: 286-292
    PubMedGoogle Scholar
  • 7 Kessler RC, Chiu WT, Demler O et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey. Replication Arch Gen Psychiatry 2005; 62: 617-627
    PubMedGoogle Scholar
  • 8 Bouquet A. Féticheurs et médecines traditionnelles du Congo (Brazzaville) Mém. O R S T O M 1969; (36) 282 http://www.docstoc.com/docs/41737230/Ficheurs-et-mecines-traditionn
    PubMedGoogle Scholar
  • 9 Sonibare MA, Gbile ZO. Ethnobotanical survey of anti-asthmatic plants in south western Nigeria Afr. J Trad CAM 2008; 5: 340-345
    PubMedGoogle Scholar
  • 10 Mike OS, Amusa NA, Raji-Esan SO et al. Ethnobotanical Survey of Anti-Cancer Plants in Ogun State. Nigeria Annals of Biological Research 2010; 1: 261-273
    PubMedGoogle Scholar
  • 11 Ibrahim JA, Muazzam I, Jegede IA et al. Ethno-medicinal plants and methods used by Gwandara tribe of Sabo Wuse in Niger state. Nigeria, to treat mental illness African Journal of Traditional, Complementary and Alternative Medicines 2007; 4: 211-218
    PubMedGoogle Scholar
  • 12 Ayandele AA, Adebiyi AO. The phytochemical analysis and antimicrobial screening of extracts of olax subscorpioidea. African Journal of Biotechnology 2007; 6: 868-870
    PubMedGoogle Scholar
  • 13 Lorke D. A new approach to practical acute toxicity testing. Arch Technol 1983; 54: 275-282
    PubMedGoogle Scholar
  • 14 Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 326-327
    PubMedGoogle Scholar
  • 15 Rodrigues ALS, Silva GL, Matteussi AS et al. Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci 2002; 70: 1347-1358
    CrossrefPubMedGoogle Scholar
  • 16 Rodrigues AL, Rocha JB, Mello CF et al. Effect of perinatal lead exposure on rat behavior in open-field and two-way avoidance tasks. Pharmacol Toxicol 1996; 79: 150-156
    CrossrefPubMedGoogle Scholar
  • 17 Voger HG, Voger WH. Drug Discovery and Evaluation-Pharmacological Assays; antidepressant activity. Springer-Verlag; Berlin heidelberg: 1997: 411
    Google Scholar
  • 18 Xu Q, Yi LT, Pan Y et al. Antidepressant-like effects of mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 715-725
    CrossrefPubMedGoogle Scholar
  • 19 Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model to assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005; 29: 571
    CrossrefPubMedGoogle Scholar
  • 20 Porsolt RD. Behavioural Despair, in antidepressants: Neurochemical, behavioural and clinical Perspectives. Ed by Enna SJ, Malick JB, Richelson E. Raven Press; New York: 1981: 121-139
    Google Scholar
  • 21 Steru L, Chermat R, Thierry B. The automated tail suspension test: a computerized device which differentiates psychotropic drugs Prog Neuropsychopharmacol. Biol Psychiatry 1987; 11: 659-671
    PubMedGoogle Scholar
  • 22 Cryan JF, Lucki I. Antidepressant-like behavioral effects mediated by 5- hydroxytry-ptamine(2C) receptors. Journal of Pharmacology and Experimental Therapeutics 2000; 295: 1120-1126
    PubMedGoogle Scholar
  • 23 Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future need. Trends in Pharmacological Sciences 2002; 23: 238-245
    CrossrefPubMedGoogle Scholar
  • 24 Porsolt RD, Anton G, Blavet N et al. Behavioral despair in rats A new animal model sensitive to antidepressive treatments. Eur J Pharmacol 1978; 47: 379-391
    CrossrefPubMedGoogle Scholar
  • 25 Varty GB, Cohen-Williams ME, Hunter JC. The antidepressant- like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test. Behav Pharmacol 2003; 14: 87-95
    CrossrefPubMedGoogle Scholar
  • 26 Lucki I. A prescription to resist proscriptions for murine models of depression. Psychopharmacology 2001; 153: 395-398
    CrossrefPubMedGoogle Scholar
  • 27 Bourin M, Fiocco AJ, Clenet F. How valuable are animal models in defining antidepressant activity?. Hum Psychopharmacol 2001; 16: 9-21
    CrossrefPubMedGoogle Scholar
  • 28 Boissier JR, Simon P. Action of caffeine on the spontaneous motility of the mouse. Arch Int Pharmacodyn Ther 1965; 158: 212-221
    PubMedGoogle Scholar
  • 29 Butterweck V, Christoffel V, Nahrsted A et al. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models. Life Sci 2003; 73: 627-639
    CrossrefPubMedGoogle Scholar
  • 30 Takahashi E, Katayama M, Nimii K et al. Additive sub threshold dose effects of cannabinoid CB1 receptor antagonist and selective serotonin re uptake inhibitor in antidepressant behavioral tests. Euro J Pharmacol 2008; 589: 149-156
    CrossrefPubMedGoogle Scholar
  • 31 Kwon S, Lee B, Kim M et al. Antidepressant-like effect of the methanolic extract from Bupleurum falcatum in the tail suspension test Prog Neuropsychopharmacol. Biol Psychiatry 2009; 34: 265-270
    PubMedGoogle Scholar
  • 32 Borsini F, Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 1988; 94: 147-160
    PubMedGoogle Scholar
  • 33 Cervo L, Samanin R. Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test. Neuropharamcology 1987; 26: 1469
    PubMedGoogle Scholar
  • 34 Sánchez-Mateo CC, Bonkanka CX, Prado B et al. Antidepressan properties of some Hypericum canariense L and Hypericum glandulosum Ait Extracts in the forced swimming test in mice. J Ethnopharmacol 2005; 97: 541-547
    CrossrefPubMedGoogle Scholar
  • 35 Leonard BE. Mechanism of action of antidepressants: relevance to understanding the psychobiology of depression?. Clin Neuropharmacol 1986; 9: 67-69
    PubMedGoogle Scholar
  • 36 Blier P, Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sc 1994; 15: 220-226
    CrossrefPubMedGoogle Scholar
  • 37 Malick JB. Potentiation of Yohimbine-induced lethality in mice: predictor of antidepressant potential. Drug Dev Res 1983; 3: 357-363
    CrossrefPubMedGoogle Scholar
  • 38 Bourin M, Poncelet M, Chermat R et al. The value of the reserpine test in psychopharmacology. Arzneimittel-Forschung/Drug Research 1983; 33: 1173-1176
    PubMedGoogle Scholar